
BGDO Annual Meeting 2022
15 janvier 2022 VirtuelThe Virtual BGDO annual meeting on Saturday 15 January will mainly focus on Immunotherapy in G-I Oncology: more specifically on Efficacy, Toxicity and Failures, Health Economics. We will also discuss the Perspectives of Immune Therapies in “G-I Cancers”.
Program
8.30 BGDO General Assembly
Session 1
Chairs: Veerle Casneuf | Jean-Luc Van Laethem – ULB Erasme, Brussels
9:00 Efficacy & Failures across tumour types
- Standard recommendation in Belgium: MSIH CRC, Liver Cancer, Upper GI Marc Peeters – UZ Antwerp
- Failures and upcoming standards Eric Van Cutsem – UZ Leuven
10:00 Toxicity of immunotherapies Karen Geboes – UZ Gent
10:30 Break
Session 2
Chairs: Alain Hendlisz- Institut Bordet Brussels | Marc Van de Eynde – UCL Saint-Luc, Brussels
10:45 Health Economics
11:30 Perspectives of Immune Therapies in “G-I Cancers”
- Fundamental Pierre Coulie ~ UCL Saint-Luc, Brussels
- Future perspectives of Immunotherapy in upper G.I. cancers Markus Möhler – Medizinische Klinik Mainz
12:30 Closing remarks Marc Peeters, BGDO chairman
Site internet : www.bgdo.org